Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
MG-132: Pioneering Precision in Proteasome Inhibition and...
2025-09-26
Explore the multifaceted role of MG-132, a potent proteasome inhibitor peptide aldehyde, in dissecting ubiquitin-proteasome system inhibition, apoptosis, and autophagy. This in-depth guide uniquely connects MG-132's molecular actions to current neurobiology breakthroughs and advanced cancer research.
-
Tamoxifen: Unveiling Noncanonical Mechanisms in Inflammat...
2025-09-25
Explore the cutting-edge roles of Tamoxifen, a selective estrogen receptor modulator, in immune modulation and chronic inflammation. This article uniquely integrates antiviral, gene knockout, and kinase inhibition functions with insights from recent T cell research, offering novel perspectives beyond traditional breast cancer research.
-
EZ Cap EGFP mRNA 5-moUTP: Engineering Translational Preci...
2025-09-24
Explore the unique role of EZ Cap EGFP mRNA 5-moUTP in engineering translational precision for immuno-oncology. This in-depth analysis reveals how advanced capping, 5-moUTP, and poly(A) tail enhancements synergize for robust mRNA delivery and immune evasion, setting new standards beyond current literature.
-
A 83-01 in Intestinal Organoid Research: Mechanistic Insi...
2025-09-23
Explore the mechanistic role of A 83-01, a selective TGF-β type I receptor inhibitor, in enhancing the fidelity and utility of human intestinal organoid models for pharmacokinetic and epithelial-mesenchymal transition (EMT) research.
-
br Conflict of interest statement
2025-03-03

Conflict of interest statement Introduction Currently, adenocarcinoma is the most common histological subtype of lung cancer. Activating mutations and translocations with a potential for targeted therapy are reported predominantly in non-smokers. ALK rearrangement is found in less than 5% of u
-
br Discussion To our knowledge
2025-03-03

Discussion To our knowledge, this is the first case report that demonstrates the presence of a novel T1151K ALK mutation in a patient with disease progression after crizotinib and then ceritinib. As early as 2011, Zhang et al. identified T1151K among other resistance mutations to crizotinib in Ba
-
br Discussion Missense mutations transversions
2025-03-03

Discussion Missense mutations (transversions) of the first nucleotide of the phenylalanine Cy3-streptavidin labeling at position 1174 (F1174) of the anaplastic lymphoma kinase gene can result in substitutions to leucine or valine (F1174L/V) while missense mutation (transversion) of the second nu
-
br Acknowledgements br Introduction Diabetic complications a
2025-03-03

Acknowledgements Introduction Diabetic complications are responsible for increased morbidity and mortality of diabetic patients. Increased flow of Calmidazolium chloride receptor through the polyol pathway under conditions of hyperglycemia contributes to the development of diabetic complicati
-
FAK Inhibitor 14 Our findings establish a critical link betw
2025-03-03

Our findings establish a critical link between HemAC-Lm dimeric structure and cAMP synthesis that helps in explaining how globin-A domain influences AC domain. The following possible homodimeric structure of wild type full length HemAC-Lm has been proposed to explain the role of this globin-A domain
-
PAN induced nephrosis was accompanied by loss of
2025-03-03

PAN-induced nephrosis was accompanied by loss of body weight, decrease of food intake, increase in urine volume and increases in triglycerides and cholesterol levels, which have been reported previously (Natori et al., 1996). Except for urine volume, each one of these measures was improved by A-3069
-
Isoxsuprine hydrochloride The altered frequency of CD T cell
2025-03-03

The altered frequency of CD4+ T Isoxsuprine hydrochloride in 5-LO−/− mice led us to hypothesize that these leukocytes could be exerting a primary control of the inflammatory response. In fact, the lack of 5-LO resulted in the accumulation of CD4+CD25+ cells expressing Treg markers. It is plausible t
-
Experimentally the ECD spectrum of showed three
2025-03-01

Experimentally, the ECD spectrum of 1 showed three ECD bands: positive ones at 260 and 200nm, and a negative one at 230nm (Fig. 4). Meanwhile, there is only one broad positive ECD band starting from 300nm in the ECD spectrum of 2. ECD spectra of 1 and its derivatives attracted great interest because
-
Studies have demonstrated that AT
2025-03-01

Studies have demonstrated that AT2 plays a greater role in modulating arterial pressure in females than in males. Chronic low-dose infusion of Ang II decreased blood pressure in female rats at a dose that had negligible effects in males. Furthermore, AT2 blockade eliminates the depressor response to
-
Pathogen infected macrophages release exosomes associating w
2025-03-01

Pathogen-infected caspase pathway release exosomes associating with pathogen-associated molecular patterns (PAMPs) such as LPS and lipoprotein derived from microorganisms [29,30]. Exosomes released by bacterially infected, but not uninfected, macrophages stimulate macrophages to release inflammator
-
br Conclusion br Conflict of interest
2025-03-01

Conclusion Conflict of interest Acknowledgements Introduction Human salivary aldehyde dehydrogenase (hsALDH) (E.C. 1.2.1.5) is the first line of defence against toxic aldehydes in the oral cavity. HsALDH is primarily a dimeric, class 3 ALDH (ALDH3A1) specific for aromatic and long/medium
16708 records 24/1114 page Previous Next First page 上5页 2122232425 下5页 Last page